SQM Q3 2026 Earnings: High Fertilizer Prices Cut Plant Nutrition Volumes

Summary
SQM's Q3 2026 specialty plant nutrition volumes fell 13% as high fertilizer prices curbed farmer demand, while lithium prices slid 10% from the second-quarter peak.
SQM's Q3 2026 earnings show profit falling back from the second-quarter peak and the volume growth in its specialty fertilizer business coming to an end. The company filed its results for the quarter ended September 30, 2026 on Form 6-K with the US Securities and Exchange Commission on November 18, 2026 [1]. Third-quarter revenue was US$2,112.0 million, up 80% year over year, and net income attributable to SQM was US$544.2 million, down from US$660.0 million in the second quarter [1][2].
Three questions framed the quarter: whether lithium prices could hold near their first-half average, whether record iodine prices could withstand new supply, and how long China's restrictions on potassium nitrate exports would keep adding to SQM's volumes. In the third quarter, SQM's realized lithium price fell 10% from the prior quarter, and the company said its fourth-quarter price could be substantially lower. Iodine revenue grew year over year with stable pricing. Specialty plant nutrition volumes fell 13% year over year, and SQM cut its full-year volume growth outlook for that business from about 10% to about 5% [1]. Taken together, SQM's production and cost base is unchanged, its profit again depends on lithium prices, and growth in its fertilizer business now rests on price alone.
SQM is a Chilean chemicals and mining company that describes itself as the world's largest producer of potassium nitrate and iodine and one of the world's largest lithium producers [3]. Its lithium comes from the Salar de Atacama and the Mt Holland mine in Australia, while iodine and potassium nitrate come from caliche ore deposits in northern Chile. In 2025, lithium, iodine and specialty plant nutrition revenue were US$2,288.2 million, US$1,042.8 million and US$982.4 million, respectively [4].
High fertilizer prices turned plant nutrition volumes negative
SQM's specialty plant nutrition business, which sells potassium nitrate and other fertilizers for high-value crops, swung from volume growth to decline in the third quarter. In the second quarter, the business sold 302.8 thousand metric tons, up 14% year over year [5]. The company's full-year volume growth outlook of about 10% rested on China's late-March 2026 suspension of potassium nitrate exports [6]. Third-quarter volumes fell to 240.5 thousand metric tons, down 13% year over year, including 114.9 thousand metric tons of potassium nitrate, down 10% [1]. SQM then lowered its full-year volume growth outlook to about 5% [1].
The decline came from demand, and China's supply constraints have not been lifted. SQM said fertilizer prices kept rising during the third quarter, which led some farmers to cut purchases of potash-based products, including potassium nitrate [1]. Management said on the earnings call that the effect was spread across more than 100 markets, with phosphates and phosphate-based NPK products hit hardest [7]. SQM still cited lower product availability from China and supply disruptions linked to the conflict in the Middle East as support, and said these conditions let it sell more in markets such as Eastern Europe and Africa [1]. The release does not quantify that additional volume.
Higher prices supported revenue but did not offset the lost volume. The business's average realized price was about US$1,119 per metric ton, up 20% year over year, and revenue was US$269.1 million, up only 4% [1]. SQM expects prices to stay broadly at current levels for the rest of the year and warned that El Niño-related rainfall could reduce fertilizer purchases along the Pacific coast [1]. The business accounted for about 5% of consolidated gross profit in the first nine months, so its direct effect on company profit is limited [1]. Still, most of the extra volume from China's export restrictions will not materialize, and the business has shifted from rising volume and price to price making up for lower volume.
Lithium prices pulled profit down while iodine prices held
SQM's lithium volumes stayed high, and the decline in profit came mainly from price. Novandino, SQM's lithium joint venture with Chile's state copper company Codelco, sold 73.3 thousand metric tons in the third quarter, up 16% year over year, at an average realized price of about US$19.6 per kilogram, down 10% from the second quarter [1]. Management said unit costs were similar to the second quarter [7], so the lower price flowed directly into profit: the consolidated gross margin was about 45.6%, down from 51.0% in the second quarter [1][2]. SQM also said market prices had declined significantly in recent weeks and that its fourth-quarter realized price could be substantially lower than in the third quarter, without giving a figure [1].
The iodine business was stable, with no sign that new supply was pushing prices down. Third-quarter iodine revenue was US$262.0 million, up 7.1% year over year; volumes were 3.6 thousand metric tons, up 5%; and the average realized price was about US$73 per kilogram, up 2% [1]. SQM attributed the decline in revenue from the second quarter to seasonality [1].
Conclusion
SQM's third-quarter results show a solid volume base, with profit conversion once again driven by lithium prices. Lithium volumes rose 8% year over year, minority interest took about 9% of after-tax profit, and the declines in gross margin and net income came from price [1]. At September 30, cash plus other current financial assets totaled about US$5,034.5 million against borrowings of about US$5,514.2 million; the release did not include a cash flow statement, so operating cash flow and capital spending cannot be checked [1]. Management kept its plan for about US$3 billion of capital spending over 2026 to 2028 [7]. The next tests are the actual size of the fourth-quarter decline in lithium prices and whether the plant nutrition business can deliver about 5% full-year volume growth at higher prices.
Sources
[1] SQM 6-K filed 2026-11-18 Q3 2026 earnings release, 2026-11-18, 6-K, https://www.sec.gov/Archives/edgar/data/909037/000090903726000042/a6-ksqmx3q2026earningsrele.htm
[2] SQM 6-K filed 2026-08-21 Q2 2026 income statement, 2026-08-21, 6-K, https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000909037&type=6-K
[3] SQM 20-F filed 2026-04-22 company overview, 2026-04-22, 20-F, https://www.sec.gov/Archives/edgar/data/909037/000090903726000023/
[4] SQM 20-F filed 2026-04-22 revenue by product line, 2026-04-22, 20-F, https://www.sec.gov/Archives/edgar/data/909037/000090903726000023/
[5] SQM 6-K filed 2026-08-21 specialty plant nutrition, 2026-08-21, 6-K, https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000909037&type=6-K
[6] SQM Q1 2026 earnings call 2026-05-26, 2026-05-26, earnings-call, https://gateway.drillr.ai/mcp/private
[7] SQM Q3 2026 earnings call 2026-11-18 (Drillr summary), 2026-11-18, earnings-call, drillr:earning_call_summary/SQM/2026-11-18